{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:36:15Z","timestamp":1792856175045,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1053\/j.ajkd.2017.07.019","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T06:31:21Z","timestamp":1505975481000},"page":"737-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":327,"title":["KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and\u00a0Treatment of Chronic Kidney Disease\u2013Mineral and Bone\u00a0Disorder (CKD-MBD)"],"prefix":"10.1053","volume":"70","author":[{"given":"Tamara","family":"Isakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Denburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri","family":"Yarlagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Nigwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2017.07.019_bib1","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorders (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"10.1053\/j.ajkd.2017.07.019_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semnephrol.2012.12.012","article-title":"Comparison of mineral metabolites as risk factors for adverse clinical outcomes in CKD","volume":"33","author":"Isakova","year":"2013","journal-title":"Semin Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2017.07.019_bib4","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"11","key":"10.1053\/j.ajkd.2017.07.019_bib5","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"4 suppl 3","key":"10.1053\/j.ajkd.2017.07.019_bib6","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2017.07.019_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"10.1053\/j.ajkd.2017.07.019_bib8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1053\/j.ajkd.2017.07.019_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2017.07.019_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","article-title":"Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease","volume":"98","author":"Denburg","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.11721111","article-title":"Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol","volume":"7","author":"Isakova","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2017.07.019_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2215\/CJN.09471209","article-title":"Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis","volume":"5","author":"Gardham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.07.019_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-017-3730-4","article-title":"Variability in measures of mineral metabolism in children on hemodialysis: impact on clinical decision-making","author":"Kakajiwala","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.07.019_bib18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.07.019_bib19","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"23","key":"10.1053\/j.ajkd.2017.07.019_bib20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI113172","article-title":"Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D","volume":"80","author":"Portale","year":"1987","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2017.07.019_bib24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2215\/CJN.10000912","article-title":"Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients","volume":"8","author":"Pun","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/j.ajkd.2015.03.038","article-title":"Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study","volume":"66","author":"Brunelli","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2017.07.019_bib27","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1359\/jbmr.2000.15.11.2245","article-title":"Calcium accretion in girls and boys during puberty: a longitudinal analysis","volume":"15","author":"Bailey","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"issue":"26","key":"10.1053\/j.ajkd.2017.07.019_bib28","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.07.019_bib29","first-page":"136","article-title":"Reexamining the phosphorus-protein dilemma: does phosphorus restriction compromise protein status?","volume":"26","author":"St-Jules","year":"2016","journal-title":"J\u00a0Ren Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2017.07.019_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2017.07.019_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib34","first-page":"97","article-title":"Replacing phosphorus-containing food additives with foods without additives reduces phosphatemia in end-stage renal disease patients: a randomized clinical trial","volume":"27","author":"de Fornasari","year":"2017","journal-title":"J\u00a0Ren Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.ackd.2012.10.008","article-title":"Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease","volume":"20","author":"Gutierrez","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2011.03.032","article-title":"Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis","volume":"58","author":"Slinin","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2017.07.019_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","article-title":"Prevalence and severity of disordered mineral metabolism in blacks with chronic kidney disease","volume":"73","author":"Gutierrez","year":"2008","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2017.07.019_bib38","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfs080","article-title":"Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD","volume":"27","author":"Ennis","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2017.07.019_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","article-title":"Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation","volume":"62","author":"Block","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3945\/ajcn.112.053934","article-title":"Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population","volume":"98","author":"Calvo","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.ajkd.2017.07.019_bib41","series-title":"Endotext","article-title":"Hyperparathyroidism in chronic kidney disease","author":"Dr\u00fceke","year":"2000"},{"issue":"6496","key":"10.1053\/j.ajkd.2017.07.019_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.291.6496.623","article-title":"Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide","volume":"291","author":"Mak","year":"1985","journal-title":"Br Med J"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.07.019_bib44","first-page":"186","article-title":"Increasing use of vitamin D supplementation in the Chronic Renal Insufficiency Cohort Study","volume":"24","author":"Mariani","year":"2014","journal-title":"J\u00a0Ren Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00041552-199607000-00008","article-title":"Molecular genetics of hyperparathyroid disease","volume":"5","author":"Tominaga","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2017.07.019_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib49","first-page":"185","article-title":"Controlled trial of calcitriol in hemodialysis patients","volume":"26","author":"Baker","year":"1986","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2017.07.019_bib51","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE Trial","volume":"26","author":"Moe","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.07.019_bib52","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1523-1755.2004.00368.x","article-title":"Parathyroidectomy rates among United States dialysis patients: 1990-1999","volume":"65","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2017.07.019_bib54","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcph.460","article-title":"Population pharmacokinetics analysis of AMG 416, an allosteric activator of the calcium-sensing receptor, in subjects with secondary hyperparathyroidism receiving hemodialysis","volume":"55","author":"Chen","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2017.07.019_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2015.04.037","article-title":"Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial","volume":"78","author":"Isakova","year":"2015","journal-title":"Bone"},{"issue":"4","key":"10.1053\/j.ajkd.2017.07.019_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/j.ajkd.2013.12.018","article-title":"Bone disease in CKD: a focus on osteoporosis diagnosis and management","volume":"64","author":"Miller","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2017.07.019_bib58","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2017.07.019_bib59","first-page":"CD005015","article-title":"Interventions for preventing bone disease in kidney transplant recipients","volume":"3","author":"Palmer","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2017.07.019_bib60","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2017.07.019_bib61","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1523-1755.2005.00306.x","article-title":"A\u00a0prospective randomized study for prevention of postrenal transplantation bone loss","volume":"67","author":"El-Agroudy","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.07.019_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-6143.2002.020111.x","article-title":"Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate","volume":"2","author":"Cruz","year":"2002","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2017.07.019_bib63","first-page":"684","article-title":"Pamidronate therapy as prevention of bone loss following renal transplantation","volume":"57","author":"Fan","year":"2000","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:01:21Z","timestamp":1759460481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617308983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272638617308983"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.07.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and\u00a0Treatment of Chronic Kidney Disease\u2013Mineral and Bone\u00a0Disorder (CKD-MBD)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}